XTX301

· Xilio Development, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XTX301, covering 2025-09-08 to 2025-09-08. Get the full timeline:

Most recent: Clinical Trial Update: XTX301 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]